The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: Single center experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 6, 2012, Pages 580-586

  Ustaalioglu, Basak Oven ^a   Bilici, Ahmet ^a   Kefeli, Umut ^a   Şeker, Mesut ^a   Oncel, Mustafa ^b,d   Gezen, Cem ^b   Gumus, Mahmut ^a   Demirelli, Fuat ^c  

^a Departments of Medical Oncology   (Turkey)

^b DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d GUMUSHANE UNIVERSITY   (Turkey)

Author keywords

breast cancer; disease free survival; multicentricity; multifocality

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CANCER; OVERALL SURVIVAL; POSTMENOPAUSE; PREMENOPAUSE; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TUMOR BURDEN; YOUNG ADULT;

EID: 84870255249     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31822d9cd6     Document Type: Article

References (18)

1. Litton JK, Eralp Y, Gonzalez-Angulo AM, et al. Multifocal breast cancer in women r35 years old. Cancer. 2007;110:1445-1450. (Pubitemid 47463057)
2. Balslev I, Axelsson CK, Zedeler K, et al. The Nottingham Prognostic Index applied to 9149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat. 1994;32:281-290. (Pubitemid 24351375)
3. Rampaul RS, Pinder SE, Elston CW, et al. Nottingham Breast Team. Prognostic and predictive factors in primary breast cancer and their role in patient management: THE Nottingham Breast Team. Eur J Surg Oncol. 2001;27:229-238. (Pubitemid 32621745)
4. Fitzgibbons PL, Page DL, Weaver D. Prognostic factors in breast cancer: COLLEGE of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:966-978.
5. Pedersen L, Gunnarsdottir KA, Rasmussen BB, et al. The prognostic influence of multifocality in breast cancer patients. Breast. 2004;13:188-193. (Pubitemid 38937121)
6. Singletary SE, Connolly JL. Breast cancer staging: Working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56:37-47. (Pubitemid 43228386)
7. Egan RL. Multicentric breast carcinomas: Clinical-radiographicpathologic whole organ studies and 10-year survival. Cancer. 1982;49:1123-1130. (Pubitemid 12187811)
8. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: Does each focus matter? J Clin Oncol. 2005;23:7497-7502.
9. Andea AA, Wallis T, Newman LA, et al. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94:1383-1390. (Pubitemid 34212630)
10. Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990. (Pubitemid 15003474)
11. Wilkinson LS, Given-Wilson R, Hall T, et al. Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol. 2005;60:573-578. (Pubitemid 40553320)
12. Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50: 735-742. (Pubitemid 32515328)
13. Vlastos G, Rubio IT, Mirza NQ, et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol. 2000;7:581-587.
14. Oh JL, Dryden MJ, Woodward WA, et al. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006;24:4971-4975. (Pubitemid 46631398)
15. Fish EB, Chapman JA, Link MA. Assessment of tumor size for multifocal primary breast cancer. Ann Surg Oncol. 1998;5: 442-446. (Pubitemid 28367070)
16. Cabioglu N, Ozmen V, Kaya H, et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009;208:67-74.
17. Rakowsky E, Klein B, Kahan E, et al. Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat. 1992;21: 121-131.
18. Yerushalmi R, Kennecke H, Woods R, et al. Does multicentric/ multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat. 2009;117:365-370.